BIOSTATISTICS, ANALYTICAL SUPPORT AND EVALUATION SHARED RESOURCE (BASE) ABSTRACT The Biostatistics, Analytical Support & Evaluation Shared Resource (BASE) goal is to provide comprehensive and high quality biostatistics support for basic and translational cancer-related research, clinical trials and population studies in the UCLA Jonsson Comprehensive Cancer Center (JCCC). The BASE Shared Resource promotes excellence in cancer research by engagement in a study from its inception to its conclusion, through statistical support on study design, data analysis, interpretation of study results, and manuscript preparation. BASE services for JCCC members also includes statistical study design prior to a grant application, with BASE statisticians supported as co-investigators when funding occurs. BASE supports two critical JCCC standing committees: the Internal Scientific Protocol Review Committee (ISPRC), by providing statistical review of clinical trials protocols, and the Data & Safety Monitoring Board (DSMB), by providing statistical support for the implementation, conduct, and monitoring of oncology clinical trials. In addition, the BASE Shared Resource collaborates closely with several campus informatics facilities to support data management for cancer studies. BASE faculty members also develop novel statistical methodologies in response to the needs of JCCC research projects to facilitate such studies. The JCCC BASE Shared Resource was established in 1994. Gang Li, PhD (ZY), an international leader in biostatistics, has been the BASE Director since 2007, and David Elashoff, PhD (ZY) serves as Co-Director. BASE includes five additional faculty members and a staff biostatistician from the UCLA Departments of Biostatistics, Biomathematics, and Medicine. These faculty members are nationally respected biostatisticians with broad expertise in general biostatistics, the design and analysis of clinical trials, bioinformatics, and the analysis and interpretation of high-dimensional high throughput data. During the previous six-year period, the BASE Shared Resource supported projects from 55 JCCC members originating in all six JCCC Research Programs, representing 85% of overall Shared Resource usage. Of this, 64% supported members with peer- review funded research and 21% members without peer-review funded research, resulting in 320 publications, 36% of which were in high-impact (IF ?10, or field leading) journals. The BASE Shared Resource assisted in a large number of cancer grant applications, with 31 successfully awarded for ~$64M in total direct cost funding. In addition, the BASE Shared Resource supported 39 cancer clinical trials during the past six-year project period. The role of the BASE Shared Resource in the facilitation of study design, data analysis, grant applications, protocol review, design, and implementation of clinical trials and data management is central to the mission of the UCLA JCCC.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016042-44
Application #
9936713
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Yu, Jingyi; Seldin, Marcus M; Fu, Kai et al. (2018) Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity. Circ Res 123:73-85
Hong, Aayoung; Moriceau, Gatien; Sun, Lu et al. (2018) Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma. Cancer Discov 8:74-93
Epeldegui, Marta; Magpantay, Larry; Guo, Yu et al. (2018) A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma. AIDS 32:945-954
Hsu, Jeffrey J; Lu, Jinxiu; Umar, Soban et al. (2018) Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice. Am J Physiol Heart Circ Physiol 314:H1203-H1213
Woo, Jin Seok; Srikanth, Sonal; Kim, Kyun-Do et al. (2018) CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. J Immunol 201:1174-1185
Patananan, Alexander N; Sercel, Alexander J; Teitell, Michael A (2018) More than a powerplant: the influence of mitochondrial transfer on the epigenome. Curr Opin Physiol 3:16-24
Heard, Jeffrey J; Phung, Ivy; Potes, Mark I et al. (2018) An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation. BMC Cancer 18:69
Kim, Roy Y; Mangu, Darian; Hoffman, Alexandria S et al. (2018) Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis. Brain 141:132-147
Pothoulakis, Charalabos; Torre-Rojas, Monica; Duran-Padilla, Marco A et al. (2018) CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis. Int J Cancer 142:334-346
Montecino-Rodriguez, Encarnacion; Casero, David; Fice, Michael et al. (2018) Differential Expression of PU.1 and Key T Lineage Transcription Factors Distinguishes Fetal and Adult T Cell Development. J Immunol 200:2046-2056

Showing the most recent 10 out of 767 publications